62 filings
F-3ASR
Glaxosmithkline Capital Inc
25 Mar 24
Automatic shelf registration (foreign)
2:01pm
25-NSE
Glaxosmithkline Capital Inc
2 Oct 23
Exchange delisting
2:40pm
EFFECT
Glaxosmithkline Capital Inc
16 Mar 23
Notice of effectiveness
12:15am
POS AM
Glaxosmithkline Capital Inc
10 Mar 23
Prospectus update (post-effective amendment)
12:20pm
25-NSE
Glaxosmithkline Capital Inc
9 May 22
Exchange delisting
10:33am
25-NSE
mk8k30i15v ppt
2 May 22
Exchange delisting
1:10pm
6-K
8rfrxpt49teqtu91r
14 Apr 22
Current report (foreign)
10:10am
25-NSE
64uddcettzdg7l 1d
14 May 21
Exchange delisting
8:35am
F-3ASR
e05nr7
26 Mar 21
Automatic shelf registration (foreign)
1:32pm
25-NSE
whrargskdgu3qclcac
13 Oct 20
Exchange delisting
12:11pm
CERT
lz4wfn 2n
7 Oct 20
Certification of approval for exchange listing
10:35am
8-A12B
iqo2v4yo
1 Oct 20
Registration of securities on exchange
2:52pm
6-K
nilyg
1 Oct 20
Current report (foreign)
2:50pm
424B2
qpkagj8
30 Sep 20
Prospectus for primary offering
10:56am
6-K
c0guyl33bgttif23ledf
29 Sep 20
Current report (foreign)
12:29pm
FWP
cop0kto0
28 Sep 20
Free writing prospectus
4:24pm
FWP
ijs8 hqg21
28 Sep 20
Free writing prospectus
4:22pm
424B2
u70 f9z3wpvj
28 Sep 20
Prospectus for primary offering
9:30am
6-K
f812 y6o1er5kqnlt
28 Sep 20
Current report (foreign)
8:53am
CERT
puk2w
29 Mar 19
Certification of approval for exchange listing
9:00am